SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-021097
Filing Date
2024-05-23
Accepted
2024-05-23 08:00:31
Documents
17
Period of Report
2024-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44651
2 ex10-1.htm EX-10.1 80669
3 ex10-2.htm EX-10.2 83685
4 ex10-3.htm EX-10.3 70462
  Complete submission text file 0001493152-24-021097.txt   494370

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgs-20240521.xsd EX-101.SCH 3018
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgs-20240521_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgs-20240521_pre.xml EX-101.PRE 22361
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3535
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 24975239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)